Thu, June 20, 2024
Tue, September 12, 2023
[ 12:00 AM ] - WOPRAI
Thu, September 7, 2023
[ 12:00 AM ] - WOPRAI
Mon, August 14, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 11, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 8, 2023
[ 12:00 AM ] - WOPRAI
Mon, July 24, 2023
[ 12:00 AM ] - WOPRAI
Thu, July 6, 2023
[ 12:00 AM ] - WOPRAI
Fri, October 15, 2021
[ 12:00 AM ] - WOPRAI
Fri, July 23, 2021
[ 12:00 AM ] - WOPRAI
Fri, June 11, 2021
[ 12:00 AM ] - WOPRAI
Mon, March 8, 2021
Wed, February 17, 2021
[ 12:00 AM ] - WOPRAI
Wed, February 3, 2021
[ 12:00 AM ] - WOPRAI
Thu, October 29, 2020
[ 12:00 AM ] - WOPRAI
Wed, October 28, 2020
[ 12:00 AM ] - WOPRAI
Mon, October 12, 2020
[ 12:00 AM ] - WOPRAI
Tue, August 11, 2020
[ 12:00 AM ] - WOPRAI
Fri, July 31, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, July 29, 2020
[ 12:00 AM ] - WOPRAI
Fri, May 8, 2020
[ 12:00 AM ] - WOPRAI
Wed, May 6, 2020
[ 12:00 AM ] - WOPRAI
Mon, May 4, 2020
[ 12:00 AM ] - WOPRAI
Fri, May 1, 2020
[ 12:00 AM ] - WOPRAI
Mon, April 20, 2020
[ 12:00 AM ] - WOPRAI
Wed, April 15, 2020
[ 12:00 AM ] - WOPRAI
Wed, March 11, 2020
[ 12:00 AM ] - WOPRAI
Fri, March 6, 2020
[ 12:00 AM ] - WOPRAI
Tue, March 3, 2020
Alethia Young Reiterated (ARWR) at Buy on, Jun 20th, 2024
Alethia Young of Cantor Fitzgerald, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy on, Jun 20th, 2024.
Alethia has made no other calls on ARWR in the last 4 months.
There are 4 other peers that have a rating on ARWR. Out of the 4 peers that are also analyzing ARWR, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024
These are the ratings of the 2 analyists that currently disagree with Alethia
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Tuesday, June 11th, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Monday, June 3rd, 2024
Contributing Sources